Kí ni “Clear” túmọ̀ sí?
Eranko ko gbe iyipada. Kii yoo ni idagbasoke arun na ati pe kii yoo kọja lori rẹ.
Discover the importance of the DNA test for Autoimmune Lymphoproliferative Syndrome (ALPS) in cats, a genetic disorder affecting the immune system. Early detection through this specialized DNA test helps identify carriers and affected cats, enabling breeders and pet owners to make informed decisions. ALPS can cause abnormal lymphocyte accumulation, leading to severe health issues in cats. By using the ALPS DNA test, you ensure better health management and prevent the spread of this hereditary condition. Trust reliable veterinary genetics labs for accurate and fast results. Protect your feline companion’s health with proactive genetic screening today. Stay informed and keep your cat safe from ALPS with cutting-edge DNA testing.
Autoimmune Lymphoproliferative Syndrome (ALPS) in cats is a rare genetic disorder affecting the immune system. A DNA test can identify mutations linked to ALPS, helping in early diagnosis. This test aids veterinarians in managing the condition and preventing severe immune complications. Early detection through genetic screening improves treatment outcomes. Responsible breeding practices can reduce the incidence of ALPS in feline populations.
Idanwo DNA yii wa pẹlu ti o bẹrẹ lati idii wa Basic - ati ki o jẹ tun apa ti awọn akopọ Basic, Standard, Advanced, Complete.
Wo Awọn akopọ Idanwo DNA →Autoimmune Lymphoproliferative Syndrome (ALPS) is a rare genetic disorder that affects the immune system of cats. It is characterized by the abnormal proliferation of lymphocytes, which are a type of white blood cell crucial for immune responses. This condition can lead to various health issues, including persistent lymphadenopathy (swollen lymph nodes), anemia, and an increased susceptibility to infections.
Cats with ALPS may display a range of clinical symptoms, including recurrent fevers, weight loss, lethargy, and skin lesions. The overproduction of lymphocytes can result in hypergammaglobulinemia, which is an elevated level of immunoglobulins in the blood. This can compromise the normal functioning of the immune system, leading to autoimmune disorders where the body mistakenly attacks its own tissues.
ALPS is primarily caused by mutations in specific genes that regulate lymphocyte apoptosis, the process of programmed cell death. In healthy cats, lymphocytes undergo apoptosis after they have completed their immune function, preventing their excessive accumulation. However, in ALPS-affected cats, the dysregulation of this process leads to the survival of excess lymphocytes, contributing to the clinical symptoms observed.
While clinical signs may suggest ALPS, a definitive diagnosis often requires genetic testing. A DNA test can identify mutations associated with the syndrome, allowing veterinarians to confirm the presence of ALPS. Early diagnosis is crucial, as it can guide treatment options and management strategies to improve the quality of life for affected cats.
Management of ALPS in cats typically involves immunosuppressive therapies to reduce lymphocyte proliferation and the associated symptoms. Corticosteroids and other immunosuppressants may be prescribed to help control the immune response. Additionally, supportive care, including proper nutrition and management of secondary infections, is essential in ensuring the well-being of affected cats.
The prognosis for cats diagnosed with ALPS can vary widely depending on the severity of the condition and the response to treatment. Regular veterinary check-ups and monitoring are essential to manage the disease effectively. Owners should be aware of the potential for recurrent infections and other complications, and they should work closely with their veterinarian to establish a comprehensive care plan tailored to their cat’s needs.
Eranko ko gbe iyipada. Kii yoo ni idagbasoke arun na ati pe kii yoo kọja lori rẹ.
Rara. Eranko naa ni ilera ni gbogbogbo ṣugbọn o le tan iyipada si rẹ ọmọ.
O gbe awọn ẹda ti o yipada meji. Awọn ami ile-iwosan ni a nireti da lori arun na. Ko yẹ ki o jẹ ajọbi.
Diẹ ninu awọn arun ti wa ni ibalopo-ti sopọ mọ, ki wọn ikosile yatọ da lori awọn ibalopo eranko.
This DNA test detects the mutation associated with Autoimmune Lymphoproliferative Syndrome (ALPS) in order to identify clear, carrier, or at-risk animals.
Idanwo DNA ṣe iranlọwọ fun awọn ajọbi gbero awọn ibarasun ailewu ati dinku eewu ti gbigbe iyipada si awọn ọmọ.
Ipo ogún ti a royin fun idanwo yii jẹ Recessive Autosomal.
This test analyses the mutation FASLG c.418dup.
Ko dandan. Itumọ da lori ilana ogún ati genotype abajade.
Aberdein Danielle, Munday John S, Gandolfi Barbara, Dittmer Keren E, Malik Richard, Garrick Dorian J, Lyons Leslie A. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats. Mamm Genome. 2017 Feb;28(1-2):47-55. doi: 10.1007/s00335-016-9668-1. Epub 2016 Oct 21.
Aṣiri rẹ, yiyan rẹ
A lo awọn kuki pataki lati ṣiṣẹ oju opo wẹẹbu naa. Awọn kuki iyan (gẹgẹbi awọn olupese akoonu ti a fi sii) jẹ alaabo nipasẹ aiyipada ati pe o ṣiṣẹ nikan ti o ba gba. O le yi yiyan rẹ pada nigbakugba nipa lilo bọtini “Awọn kuki”.
Ti beere fun mojuto awọn ẹya ara ẹrọ ati aabo. Nigbagbogbo ṣiṣẹ.
Ṣe ilọsiwaju awọn ẹya bii fifipamọ ayanfẹ tabi awọn ifibọ ti kii ṣe ipolowo.
Ṣe iranlọwọ fun wa ni oye lilo aaye. Alaabo nipasẹ aiyipada.
Ipolowo/titele kọja awọn aaye (diẹ ninu awọn ifibọ fidio/awọn maapu). Alaabo nipasẹ aiyipada.